About
Dr Brooke is the Chief Executive Officer of the Lung Foundation Australia, a national charitable organisation that aims to make lung health a priority for all Australians.
Mark Brooke has over 25 years’ experience leading a diverse range of medical research, consumer health and family support organisations. His previous appointments include CEO of HeartKids Limited – the National Congenital Heart Disease Foundation, CEO of Asthma Australia and CEO of Playgroup Queensland.
In the last 5 years, he has led the co-design and development of three Australian Government National Health Strategies for a wide range of health areas including asthma, congenital heart disease and, most recently, the National Lung Health Strategy, which was launched in February 2019.
As CEO of Lung Foundation Australia, he led the translation of research into programs and services to support people impacted by lung disease and lung cancer. Lung Foundation is the largest non-government organisation support patients and carers living with lung diseases and currently advises Federal and State Governments on lung health policy.
Mark is Chairperson the Global Lung Cancer Patient Advisory Council, a Board Member of the Australian Patient Advocacy Organisations Alliance; and a Board Members of ALCAN.
The CRE-PF will address the significant gap in our understanding of and ability to manage Interstitial Lung Disease. The Lung Foundation, with its expertise in implementing disease-based programs, will provide the critical link to support the translation of research into resources for use by patients, carers, policy makers and clinicians, regardless of their clinical setting.